Abbvie Inc (NYSE:ABBV) has a beta value of 0.50 and has seen 1.32 million shares traded in the recent trading session. The company, currently valued at $328.64B, closed the recent trade at $186.05 per share which meant it lost -$5.47 on the day or -2.86% during that session. The ABBV stock price is -17.53% off its 52-week high price of $218.66 and 11.95% above the 52-week low of $163.81. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.96 million shares traded. The 3-month trading volume is 6.92 million shares.
The consensus among analysts is that Abbvie Inc (ABBV) is Buy stock at the moment, with a recommendation rating of 1.87. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 7 out of 27 have rated it as a Hold, with 20 advising it as a Buy. 0 have rated the stock as Underweight.
Abbvie Inc (NYSE:ABBV) trade information
Sporting -2.86% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ABBV stock price touched $186.05 or saw a rise of 5.8%. Year-to-date, Abbvie Inc shares have moved 9.50%, while the 5-day performance has seen it change -1.96%. Over the past 30 days, the shares of Abbvie Inc (NYSE:ABBV) have changed -3.31%. Short interest in the company has seen 14.7 million shares shorted with days to cover at 2.5.
Wall Street analysts have a consensus price target for the stock at $217.5, which means that the shares’ value could jump 14.46% from the levels at last check today.. The projected low price target is $215.0 while the price target rests at a high of $220.0. In that case, then, we find that the latest price level in today’s session is -18.25% off the targeted high while a plunge would see the stock gain -15.56% from the levels at last check today..
Abbvie Inc (ABBV) estimates and forecasts
The company’s shares have gained 6.21% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -14.67% over the past 5 years. Earnings growth for 2025 is a modest 19.34% while over the next 5 years, the company’s earnings are expected to increase by 15.26%.
ABBV Dividends
Abbvie Inc is expected to release its next earnings report on 2025-Apr-25 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 6.47 at a share yield of 3.48%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 3.91%.
Abbvie Inc (NYSE:ABBV)’s Major holders
Insiders own 0.10% of the company shares, while shares held by institutions stand at 74.40% with a share float percentage of 74.47%. Investors are also buoyed by the number of investors in a company, with Abbvie Inc having a total of 4632.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 170.66 million shares worth more than $29.27 billion. As of 2024-06-30, VANGUARD GROUP INC held 9.6472% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 136.43 million shares as of 2024-06-30. The firm’s total holdings are worth over $23.4 billion and represent 7.7124% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . As of Mar 31, 2025 , the former fund manager holds about 3.16% shares in the company for having 55.77 shares of worth $10.37 billion while later fund manager owns 49.05 shares of worth $9.12 billion as of Mar 31, 2025 , which makes it owner of about 2.78% of company’s outstanding stock.
